The neonicotinoid insecticide imidacloprid has been steadily declining, the price of upstream raw materials has been stable and supported, most mainstream manufacturers have started operations stably, the transaction space for new orders is relatively normal, and the overall market sentiment in the downstream market has remained weak.
